Myocardial Dysfunction and Adrenergic Cardiac Innervation in Patients With Insulin-Dependent Diabetes Mellitus  by Scognamiglio, Roldano et al.
Myocardial Dysfunction and Adrenergic Cardiac Innervation in
Patients With Insulin-Dependent Diabetes Mellitus
ROLDANO SCOGNAMIGLIO, MD, ANGELO AVOGARO, MD, DARIO CASARA, MD,
CRISTINA CREPALDI, MD, MARCO MARIN, MD, MONICA PALISI, MD,
ROBERTO MINGARDI, MD, GIUSEPPE ERLE, MD, GIUSEPPE FASOLI, MD,
SERGIO DALLA VOLTA, MD
Padua, Italy
Background. Insulin-dependent diabetes mellitus (IDDM) is
associated with an increased incidence of heart failure due to
several factors, and in some cases a specific cardiomyopathy has
been suggested.
Objectives. This study sought to assess the mechanisms of
exercise-induced left ventricular (LV) dysfunction in asymptom-
atic patients with IDDM in the absence of hypertensive or
coronary artery disease.
Methods. Fourteen consecutive patients with IDDM were en-
rolled (10 men, 4 women; mean [6SD] age 28.5 6 6 years); 10
healthy subjects matched for gender (7 men, 3 women) and age
(28.5 6 3 years) constituted the control group. LV volume, LV
ejection fraction (LVEF) and end-systolic wall stress were calcu-
lated by two-dimensional echocardiography at rest and during
isometric exercise. LV contractile reserve was assessed by post-
extrasystolic potentiation (PESP) obtained by transesophageal
cardiac electrical stimulation and dobutamine infusion. Myocar-
dial iodine-123 metaiodobenzylguanidine (MIBG) scintigraphy
was performed to assess adrenergic cardiac innervation.
Results. Diabetic patients were classified into group A (n 5 7),
with an abnormal LVEF response to handgrip (42 6 7%), and
group B (n 5 7), with a normal response (72 6 8%). Baseline LVEF
was normal in both group A and B patients (60 6 6% vs. 61 6 7%,
p 5 NS). In group A patients, the LV circumferential wall stress–
LVEF relation showed an impairment in LVEF disproportionate to
the level of LV afterload. No significant changes in LVEF occurred
during dobutamine (60 6 6% vs. 64 6 10%, p 5 NS), whereas PESP
significantly increased LVEF (60 6 6% vs. 74 6 6%, p < 0.001);
PESP at peak handgrip normalized the abnormal LVEF (42 6 7% vs.
72 6 5%, p < 0.001); and MIBG uptake normalized for body weight
or for LV mass was lower than that in normal subjects (1.69 6 0.30
vs. 2.98 6 0.82 cpm/MBq per g, p 5 0.01) and group B diabetic
patients (vs. 2.79 6 0.94 cpm/MBq per g, p 5 0.01). Finally, a strong
linear correlation between LVEF at peak handgrip and myocardial
MIBG uptake normalized for LV mass was demonstrated in the
study patients.
Conclusions. Despite normal contractile reserve, a defective
blunted recruitment of myocardial contractility plays an impor-
tant role in determining exercise LV dysfunction in the early
phase of diabetic cardiomyopathy. This abnormal response to
exercise is strongly related to an impairment of cardiac sympa-
thetic innervation.
(J Am Coll Cardiol 1998;31:404–12)
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Patients with insulin-dependent diabetes mellitus (IDDM)
appear to have an increased likelihood of developing conges-
tive heart failure (1,2). Possible mechanisms for myocardial
dysfunction include multiple factors, such as a combination of
altered substrate metabolism (3), coronary macrovascular and
microvascular angiopathy and hypertensive disease (4). How-
ever, cardiac problems in diabetic patients cannot always be
attributed to these causes, and a specific cardiomyopathy has
been suggested (5) as a causal factor producing the increase in
cardiac mortality and morbidity. The concept of cardiomyop-
athy implies a time-dependent development of cardiac muscle
disease, which includes a period when symptoms and abnormal
signs are not present. Subclinical left ventricular (LV) systolic
(6) or diastolic (7) dysfunction, or both, may be observed at
rest and more often during exercise. The relation between LV
dysfunction induced by exercise and contractile function rep-
resents a very intriguing problem. In fact, it has been demon-
strated (8) that an abnormal LV ejection fraction (LVEF)
response to exercise cannot be equated with the presence of
abnormal myocardial contractile reserve; and more recently, a
defective inotropic recruitment has been shown (9) to play an
important role in determining an abnormal left ventricular
response to exercise despite a normal inotropic reserve. In
light of these observations, the aim of the present study was to
investigate the mechanisms of exercise-induced LV dysfunc-
tion in asymptomatic patients with IDDM. In particular, we
related LV contractile function, assessed by post-extrasystolic
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potentiation (PESP) and dobutamine infusion, to cardiac
adrenergic function measured by assessing adrenergic myocar-
dial innervation using scintigraphic imaging with iodine-123
metaiodobenzylguanidine (MIBG).
Methods
Study patients. We studied 14 consecutive asymptomatic
patients with IDDM (10 men, 4 women; mean [6SD] age
28.5 6 6 years) who fulfilled the following inclusion criteria: 1)
no overt long-term diabetic complications; 2) no overt heart
disease; 3) blood pressure ,150 mm Hg systolic and
,90 mm Hg diastolic; 4) no major additional risk factors for
coronary artery disease (i.e., blood cholesterol concentration
#5.2 mmol/liter, no smoking); 5) absence of electrocardio-
graphic (ECG) signs and clinical history of myocardial
infarction; 6) no angina pectoris; 7) absence of ischemic ST
segment changes induced by isotonic and isometric exercise;
8) no LV wall motion abnormalities induced by isometric
exercise; 9) no evidence of significant obstruction in coro-
nary vessels by coronary angiography; 10) serum creatinine
,1.2 mg/dl; and 10) no assumption of any drugs known to
affect cardiac function or to interfere with myocardial
MIBG uptake.
In addition, 10 healthy control subjects matched for gender
(7 men, 3 women), body mass index (23.6 6 1.4 vs. 23.1 6 1.3
g/m2, p 5 NS) and age (28.5 6 3 years) were recruited to
perform PESP isometric exercise and myocardial MIBG scin-
tigraphy.
Study protocol. The study protocol was approved by the
local ethics committee, and informed consent was obtained
from all participants. Assessment of the study cohort included
1) assessment of retinal and renal long-term diabetic compli-
cations; 2) determination of the degree of metabolic control; 3)
coronary angiography; 4) LV function study at rest and during
isometric exercise by quantitative two-dimensional echocardi-
ography; 5) assessment of LV contractile function at rest by
dobutamine infusion and PESP; 6) evaluation of LV contrac-
tile function during isometric exercise by PESP; 7) evaluation
of autonomic cardiac innervation by MIBG scintigraphy.
Assessment of degree of metabolic control. All participants
were asked to fast for at least 12 h before the blood sampling.
Blood samples were taken without cuffing to determine plasma
glucose, hemoglobin A1c, electrolytes and creatinine levels and
lipid profile. Patients with IDDM were all able to self-monitor
their plasma glucose levels at least three times a day, both in
the fasting condition and 2 h after principal meals. A complete
lifestyle questionnaire to obtain medical histories, parental
history of cardiovascular disease, information on smoking
habits and physical activity was completed by each patient, and
answers were discussed with one of the physicians (A.A.). The
metabolic variables are reported in Table 1.
Assessment of retinal and renal long-term diabetic compli-
cations. The fundus oculi was examined by a trained ophthal-
mologist, and each patient was classified according to the
presence or absence of diabetic retinopathy; 24-h microalbu-
minuria was measured for 3 days.
MIBG scintigraphy. Myocardial MIBG scintigraphy was
performed in diabetic patients and control subjects. Thyroid
blockade was achieved with potassium iodide (Lugol’s solu-
tion) for several days before the study. Participants were
instructed to avoid tea, coffee and alcoholic beverages on the
day of the study. Otherwise, diabetic patients consumed their
regular diets, and insulin was administered as usual. After a
30-min rest period, a dose of 100 to 185 MBq of I-123 MIBG
was slowly infused intravenously. A dynamic acquisition was
performed 1 h after injection in the left anterior oblique
position (40°) for a better visualization of the left ventricle by
means of a large field of view gamma camera (Siemens
Medical System) equipped with a high resolution low energy
collimator. The set of scintigraphic images consisted of 10
consecutive frames, each of 6 min, for a duration of 1 h,
recorded and processed on a dedicated computer (Max Delta,
Microvax Digital). Equivalent regions of interest (ROIs) of the
left ventricle and lung were established to calculate both the
heart/lung ratio and myocardial I-123 MIBG washout and to
assess adrenergic cardiac innervation. The following variables
were measured: 1) I-123 MIBG myocardial half-life (washout),
expressed in minutes and determined from heart and lung
curves; 2) heart/lung ratio, measured from equivalent ROIs
referred to LV and lung tissue uptake; 3) sympathetic myocar-
dial innervation, evaluated through the calculation of cpm/
administered dose, normalized for body weight (expressed as
cpm/MBq per kg) or for LV myocardial mass (expressed as
cpm/MBq per g) calculated by two-dimensional echocardiog-
raphy.
Echocardiographic analysis. Echocardiographic examina-
tions were performed with a Hewlett-Packard 77030A phase
array ultrasonoscope and a 2.5- or 3.5-MHz transducer. Echo-
cardiographic studies were coded and read by two independent
observers (R.S., G.F.) in blinded manner, with no knowledge
of to the patient’s identity and experimental condition. Echo-
cardiographic analysis was performed using the digitized cine
loop method (Prevue III System, Nova Microsonics, Inc.). Wall
motion and myocardial thickening were detected by examining
echocardiographic images of the left ventricle obtained in the
apical four- and two-chamber views and in the parasternal
long- and short-axis views. LV wall motion was analyzed by
repeated viewing. Agreement of interobserver analysis for
segmental asynergy was seen in 98% of the segments visual-
ized; discrepancies were resolved by consensus. LV volumes
Abbreviations and Acronyms
ECG 5 electrocardiographic
IDDM 5 insulin-dependent diabetes mellitus
I-123 MIBG 5 iodine-123 metaiodobenzylguanidine
LV 5 left ventricular
LVEF 5 left ventricular ejection fraction
PESP 5 post-extrasystolic potentiation
ROI 5 region of interest
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were calculated by an ellipsoid biplane area–length method
(10). LVEF was derived as end-diastolic volume minus end-
systolic volume divided by end-diastolic volume. LV endocar-
dial echocardiograms in the apical four- and two-chamber
views, for a minimum of two to four cardiac cycles, were
digitized at end-diastole (R wave peak) and end-systole (time
of smallest cavity area) by two independent observers. A
discrepancy .10 ml for LV volume required the analysis of the
echocardiographic tracing by a third observer; agreement was
achieved by consensus. However, interobserver and intraob-
server variability for LV area (r 5 0.94 and r 5 0.98,
respectively) and for LV length (r 5 0.95 and r 5 0.96,
respectively) was acceptable. LV mass was calculated by mul-
tiplying LV myocardial volume by the specific weight of the
myocardium (1.05) (11). Calibration of the carotid pulse
tracings was performed at rest and during isometric exercise,
with assignment of systolic blood pressure to the peak and
diastolic blood pressure to the nadir of the tracing (12). Linear
interpolation to the level of the incisura was then performed to
estimate end-systolic pressure. LV end-systolic circumferential
wall stress (kdynes/cm2) was calculated by S 5 (1.332PD/2h)/
(1 2 h/D 2 D2/2L2), where P 5 end-systolic pressure (simul-
taneous with LV echocardiographic measurements); D 5 LV
end-systolic short-axis diameter (in parasternal short-axis
view); h 5 LV wall thickness; and 1.332 is the factor to convert
from mm Hg to kdynes/cm2 (13). Wall stress was calculated at
rest, during handgrip testing and during dobutamine infusion.
Isometric exercise. Handgrip testing was performed with
the patient supine. Arterial pressure was measured every 30 s
by an oscillometric method (Nippon Colin Co. Ltd.), and LV
function was continuously monitored by two-dimensional
echocardiography. Maximal voluntary contraction was deter-
mined by means of a handgrip dynamometer. Isometric exer-
cise was performed for 3 min at 40% maximal voluntary
contraction. Patients were instructed to avoid performing the
Valsalva maneuver during handgrip. Left ventricular function
was assessed before and every 30 s during exercise. Heart rate
and electrocardiographic tracings were continuously moni-
tored.
Post-extrasystolic potentiation. A quadripolar electrode
catheter for transesophageal cardiac stimulation (interelec-
trode distance 2 to 3 cm) was passed through the nares into the
distal esophagus. The lead was secured where the unipolar
atrial electrogram, recorded from the middle electrodes, ex-
hibited the greatest amplitude and the most rapid deflection.
In this position, consistent and constant atrial capture was
achieved by means of a programmable stimulator with a pulse
width of 10 ms and an amplitude of 15 mA. A bipolar single
atrial extrastimulus was delivered from the two middle elec-
trodes every seventh sensed, spontaneous sinus beat. At the
Table 1. Clinical Characteristics of Study Patients and Control Group*
Pt No./Gender
Age
(yr)
Duration
of IDDM (yr)
BMI
(kg/m2)
HbA1c
(%)
FPG
(mg/dl)
AER
(mg/day)
Diabet
Retinop
Na
(mEq/liter)
K
(mEq/liter)
IR
(U/day)
Group A
(n 5 7)
1/F 46 12 20.9 8.1 12.3 5 A 140 4.3 42
2/F 26 11 21.3 8.7 16.4 10 P 132 5.1 24
3/M 31 6 22.0 9 5.8 6 A 141 4.6 34
4/M 27 11 23.9 8.3 8.4 9 A 141 4.6 49
5/M 23 2 24.2 7.5 4.2 28 A 145 4 22
6/M 31 7 21.0 7.4 2.1 5 A 137 4.4 74
7/M 24 10 23.4 8.6 16 2 P 138 4.6 36
Mean 29.7 8.4 22.3 8.2† 9.3 9.2 139.1 4.5 40.1
SD 7.8 3.5 1.4 0.6 5.7 8.6 4.0 0.3 17.6
Group B
(n 5 7)
8/M 26 14 22.2 7.9 11 15 A 142 4.2 39
9/M 27 7 25.3 8.5 6 8 A 143 4.1 18
10/M 29 7 25.4 8.9 10 8 A 141 4.2 56
11/M 28 10 23.4 7.6 4 10 A 142 4.3 35
12/M 26 6 24.2 9 6.4 12 P 142 5.7 56
13/F 20 2 24.2 8 12 6 A 142 4 28
14/F 36 12 22.8 8.4 8.2 5 A 139 3.9 60
Mean 27.4 8.2 23.9 8.3† 8.2 9.1 143 4.3 41.7
SD 4.7 4.0 1.2 0.5 2.9 3.4 2.7 0.6 16
Normal subjects
(n 5 10)
Mean 28.5 23.6 5.2 7.7 8 141 4.3
SD 3 1.4 0.5 1.2 2 2 0.3
*p 5 NS for intergroup patient analysis. †p , 0.01 versus normal subjects. A 5 absent; AER 5 albumin excretion rate; BMI 5 body mass index; Diabet Retinop 5
diabetic retinopathy by fundus oculi examination; FPG 5 fasting plasma glucose; Group A 5 Diabetic patients with abnormal left ventricular response to exercise;
Group B 5 Diabetic patients with normal left ventricular response to exercise; Hb 5 hemoglobin; IDDM 5 insulin-dependent diabetes mellitus; IR 5 insulin
requirement; P 5 present; Pt 5 patient.
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baseline assessment, the coupling interval between the spon-
taneous sinus beat and the induced extrasystole was progres-
sively decreased by 10-ms increments from 500 to 300 ms. The
post-extrasystolic beat was then allowed to occur spontane-
ously according to the patient’s intrinsic rhythm. During the
procedure, LV volumes were monitored by echocardiography,
and only beats without significant changes in LV end-diastolic
volume (increase ,10% from control value) were considered
for analysis. PESP was repeated at peak handgrip using a
coupling interval ranging from 400 to 300 ms. The procedures
produced no complications or significant patient discomfort.
Dobutamine echocardiography. Dobutamine echocardiog-
raphy was performed 1 h after the PESP procedure. A quad
screen, continuous loop was used to simultaneously compare
rest images with dobutamine and recovery images. Dobut-
amine was infused intravenously by an infusion pump at
10 mg/kg for 5 min. Patients underwent continuous ECG
monitoring, and blood pressure was recorded every 30 s. LV
wall motion, LV volumes and LVEF were assessed before and
at the fifth minute of infusion.
Coronary angiography. Coronary cineangiography was
performed in all study patients using the Judkins technique; all
examinations were evaluated in blinded manner.
Tests for cardiovascular autonomic nervous function. As-
sessment was performed at least 3 h after the last insulin
injection and included standard autonomic function tests by
measuring heart rate variability during three standardized
Valsalva maneuvres (blowing against 40 mm Hg for 15 s), heart
rate variability on deep breathing and heart rate variability and
blood pressure variability on lying to standing (14).
Laboratory analysis. Plasma glucose was assayed using a
glucose analyzer (Beckman). Hemoglobin A1c was determined
with a high performance liquid chromatographic method (15).
Microalbuminuria was determined by the method of Keen and
Chlouverakis (16). Sodium and potassium were measured with
an automated assay.
Statistical analysis. Results are expressed as mean value 6
SD. Multiple comparisons were performed by two-way re-
peated measures analysis of variance, followed by the Fisher
protected least significant difference test. Correlations and
regressions were determined by a linear least squares method.
A p value #0.05 by the two-tailed test was considered to
indicate statistical significance.
Results
Patients with IDDM were classified into two groups on the
basis of their response to isometric exercise: group A included
patients with an abnormal LVEF response to exercise (defined
as a decline .0.05 U); group B included patients with a normal
LV response (increase or no change in LVEF at peak hand-
grip). Women were equally distributed between groups A and
B (40% vs. 42%, p 5 NS).
Baseline LV function. Baseline characteristics of normal
subjects and study patients are shown in Table 2. Measure-
ments of LV end-diastolic volume (64 6 9 ml/m2, range 54 to
74) and LVEF (60 6 9%, range 57% to 70%) in the control
group were used to determine the mean and the 95% confi-
dence limits of normal values. In diabetic patients, the base-
line mean values of LV end-diastolic volume and LVEF did
not differ compared with those of control subjects. Three
patients (two in group A, one in group B) had an enlarged left
ventricle, as indicated by an LV end-diastolic volume index
greater than the upper normal limit. All patients showed a
normal LVEF. Heart rate and systolic and diastolic blood
pressures did not differ between diabetic patients and control
subjects.
LV response to handgrip (Table 2). Myocardial ischemia
was not induced by isometric exercise as assessed by the
appearance of wall motion abnormalities or ST segment
changes. Heart rate and systolic blood pressure increased at
peak exercise in both groups of diabetic patients and in normal
subjects without significant differences. LVEF response to
handgrip in the control group was characterized by a .0.05-U
increase in all but two subjects, who showed no change during
isometric exercise (mean baseline value 60 6 9% vs. mean
peak value 78 6 8%, p , 0.005). Seven of the diabetic patients
had a .0.05-U decline in LVEF (group A); peak LVEF was
significantly lower than the baseline value (42 6 7% vs. 60 6
6%, p , 0.001). The remaining seven diabetic patients had a
normal LV response to handgrip (five had a significant in-
crease, whereas two showed no change, in LVEF [group B]).
At peak handgrip, LVEF was greater in group B than in group
A patients (72 6 8% vs. 42 6 7%, p , 0.001), whereas LV
end-diastolic volume, heart rate and systolic and diastolic
blood pressures did not differ. LVEF values at rest did not
differ in patients with an abnormal response to isometric
Table 2. Baseline and Peak Handgrip Variables
Normal
Subjects
(mean 6 SD)
Diabetic Patients
Group A
(mean 6 SD)
Group B
(mean 6 SD)
Baseline
HR (beats/min) 62 6 14 67 6 9 70 6 14
SBP (mm Hg) 122 6 7 122 6 12 133 6 17
DBP (mm Hg) 76 6 7 74 6 7 75 6 11
LVEDVI (ml/m2) 64 6 9 66 6 12 63 6 10
LVESVI (ml/m2) 26 6 6 29 6 4 28 6 8
LVEF (%) 60 6 9 60 6 6 61 6 7
LVESS (kdynes/cm2) 220 6 49 229 6 52 218 6 64
Peak handgrip
HR (beats/min) 89 6 16 81 6 10 83 6 12
SBP (mm Hg) 154 6 30 156 6 15 158 6 18
DBP (mm Hg) 90 6 19 95 6 14 100 6 14
LVEDVI (ml/m2) 80 6 9 76 6 12 82 6 15
LVESVI (ml/m2) 18 6 6 43 6 7* 22 6 10†
LVEF (%) 78 6 8 42 6 7* 72 6 8†
LVESS (kdynes/cm2) 328 6 54 364 6 48 336 6 60
*p , 0.001, normal subjects versus diabetic patients. †p , 0.001, Group A
versus Group B. DBP 5 diastolic blood pressure; HR 5 heart rate; LVEDVI 5
left ventricular end-diastolic volume index; LVEF 5 left ventricular ejection
fraction; LVESS 5 left ventricular end-systolic stress; LVESVI 5 left ventricular
end-systolic volume index; SBP 5 systolic blood pressure.
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exercise, in patients with a normal response and in normal
subjects (60 6 6%, 61 6 7% and 60 6 9% respectively).
Circumferential wall stress–LVEF relation. When control
points obtained at rest and during handgrip were considered,
the relation between LV circumferential wall stress and LVEF
during exercise was linear for normal subjects, with a correla-
tion coefficient of 0.82. As shown in Figure 1, values for group
A patients were downwordly displaced and fell below the 95%
confidence interval, showing an impairment of ejection perfor-
mance that was disproportionate to the degree of afterload
during handgrip.
PESP potentiation (Table 3). PESP significantly increased
LVEF both in group A (60 6 6% vs. 74 6 6, p , 0.001) and
in group B patients (61 6 7% vs. 72 6 5, p , 0.001). To further
clarify the etiology of LV dysfunction by exercise in diabetic
patients, PESP was performed at peak handgrip. PESP signif-
icantly increased LVEF at peak exercise in group A (72 6 5%
vs. 42 6 7%, p , 0.001), whereas no significant changes occurred
in group B (75 6 4% vs. 72 6 5%, p 5 NS). In group A patients,
potentiated peak handgrip LVEF did not differ from potentiated
values at rest (75 6 4% vs. 72 6 5%, p 5 NS).
Dobutamine echocardiography. On dobutamine adminis-
tration, mean LVEF improved significantly (74 6 5% vs. 61 6
7%, p 5 0.001) in group B patients, but no significant changes
occurred in group A patients (64 6 10% vs. 60 6 6%, p 5 NS)
(Fig. 2). LV asynergies did not appear during dobutamine
infusion in either group of patients.
Cardiovascular autonomic nervous function. Traditional
autonomic function tests did not reveal any differences be-
tween the two groups of diabetic patients or between patients
and normal subjects.
MIBG scintigraphy (Fig. 3). MIBG myocardial half-life
was reduced in diabetic patients compared with that in control
subjects (332 6 68 vs. 472 6 40 min, p , 0.05), with groups A
and B exhibiting similar values (330 6 44 vs. 334 6 67 min, p 5
NS). Calculation of cpm/administered dose did not reveal
differences between normal subjects and group B diabetic
patients when values were normalized for body weight (4.97 6
0.92 vs. 5.09 6 0.85 cpm/kg, p 5 NS) or for LV myocardial
mass (2.98 6 0.82 vs. 2.79 6 0.94 cpm/g, p 5 NS). MIBG
uptake normalized for body weight or for LV myocardial mass
was significantly lower in group A diabetic patients with an
abnormal LV response to handgrip than in both normal
subjects (3.82 6 1.03 vs. 4.97 6 0.92 cpm/MBq per kg, p ,
0.05; 1.69 6 0.30 vs. 2.98 6 0.82 cpm/MBq per g, p 5 0.01) and
group B patients with a normal LV response to exercise
(3.82 6 1.03 vs. 5.09 6 0.85 cpm/MBq per kg, p , 0.05; 1.69 6
0.30 vs. 2.79 6 0.94 cpm/MBq per g, p 5 0.01). Finally, the
Figure 1. Relation between LVEF and LV circumferential
end-systolic wall stress at rest and at peak handgrip. Open
symbols 5 baseline values in normal subjects (squares),
group A patients (triangles) and group B patients (circles);
solid symbols 5 values at peak exercise in normal subjects
(squares), group A patients (triangles) and group B patients
(circles); dashed lines 5 95% confidence limit of relation in
normal subjects.
Table 3. Left Ventricular Function During Inotropic Stimulation by Post-Extrasystolic Potentiation or Dobutamine Infusion
Group A (mean 6 SD) Group B (mean 6 SD)
Base PESP Dob Base PESP Dob
LVEDVI (ml/m2) 66 6 12 68 6 9 68 6 9 63 6 10 64 6 8 60 6 10
LVESVI (ml/m2) 29 6 4 18 6 5*† 24 6 5 28 6 8 18 6 4* 16 6 6‡
LVEF (%) 60 6 6 74 6 6*† 64 6 10 61 6 7 72 6 5* 74 6 5‡§
LVESS (kdynes/cm2) 229 6 52 — 236 6 48 218 6 64 — 229 6 58
HR (beats/min) 67 6 9 — 72 6 12 70 6 14 — 74 6 18
SBP (mm Hg) 122 6 12 — 128 6 19 133 6 17 — 144 6 25
DBP (mm Hg) 74 6 7 — 85 6 12 85 6 11 — 85 6 20
*p , 0.001 versus baseline (Base) values. †p , 0.005, post-extrasystolic potentiation (PESP) versus dobutamine (Dob). ‡p , 0.001, dobutamine versus baseline
values. §p , 0.005. Other abbreviations as in Table 2.
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relation between LVEF at peak handgrip and myocardial
uptake normalized for LV mass exhibited a significant negative
correlation (y 5 10x 1 31, r 5 0.68, p 5 0.0063, SD 9.86) (Fig.
4).
Coronary angiography. Significant (.50%) coronary ste-
nosis could not be detected in any patient by selective coronary
angiography.
Discussion
The major finding of the present study is that the abnormal
LV response to isometric exercise in patients with IDDM
without apparent long-term diabetic complications is strongly
related to a functional impairment of cardiac sympathetic
innervation.
Myocardial contractility assessment by PESP. In the
present study, cardiac inotropism was stimulated by two inter-
ventions (PESP and dobutamine) acting with different mech-
anisms. PESP, as part of the force–interval relation represents
an inotropic stimulus clearly independent of variations in
diastolic ventricular filling because it has been demonstrated in
the isovolumetrically contracting heart (17). In the ejecting
ventricle, when the premature beat is followed by a compen-
satory pause, LV end-diastolic volume may be augmented, and
this increased preload contributes to the enhanced perfor-
mance. To minimize these changes in preload, only potentiated
beats without significant changes in LV end-diastolic volume
were evaluated in the present clinical study. Moreover, the
maximal rate of ventricular pressure can be affected if after-
load falls sufficiently. However, it does not appear likely that
this would occur in the intact patient, given the relatively short
test interval used to evaluate the force–interval relation. This
assumption is supported by cardiac catheterization studies in
which the plateau of restitution was sustained for .1,000 ms.
During this period, aortic diastolic pressure would have fallen
significantly, yet the maximal rate of rise of pressure appears to
have been unaffected (18). Finally, calcium availability at the
level of the myofibrills is a critical determinant of PESP, but
the interaction at the beta-adrenoceptor and increases in
intracellular cyclic adenosine monophosphate (cAMP) con-
centration play little direct role in PESP. Thus, PESP is a
potent contractile stimulus dependent on the sarcoplasmic
reticulum function and on the calcium sensitivity of contractile
Figure 2. Changes in LVEF induced by dobutamine ino-
tropic stimulation in study patients. Squares 5 Group A;
circles 5 Group B.
Figure 3. Scintigraphic images ob-
tained for three individual patients:
(A) normal cardiac MIBG uptake;
(B) heterogeneity in MIBG distribu-
tion; and (C) severe reduction in
cardiac MIBG uptake. Numbers 5
ROIs of LV myocardial wall (area 1)
and lung background (areas 2 and
5).
409JACC Vol. 31, No. 2 SCOGNAMIGLIO ET AL.
February 1998:404–12 MYOCARDIAL DYSFUNCTION IN DIABETIC PATIENTS
proteins (19). In contrast, the inotropic stimulus induced by
dobutamine is mediated by the interaction with myocyte
adrenoceptor and by the secondary increase in intracellular
cAMP.
Muscle and sympathetic fiber function in diabetic heart.
Several previous studies have demonstrated an abnormal
response of LVEF to exercise in a large subset of young adult
patients with IDDM (20–23), although baseline myocardial
contractility was normal (8,9). In our study patients, contractile
reserve, defined as the capability to improve LV pump function
by PESP, was normal in all study patients regardless of LVEF
response to exercise. However, dobutamine infusion increased
LVEF in diabetic patients with a normal response to exercise
but failed to improve LVEF in diabetic patients with LV
dysfunction induced by exercise. The afterload–LVEF relation
has been used to examine myocardial contractility in isolated
papillary muscle and in clinical investigations (24–26). The
response of the left ventricle to a sustained increase in
afterload during exercise in normal subjects is described by a
linear correlation: The increase in LV afterload is matched by
an adequate increase in myocardial contractility. Sustained
static muscular contraction increases heart rate and blood
pressure, imposing a pressure load on the left ventricle.
Activation of fast-twitch fibres during static contraction stim-
ulates unmyelinized free nerve endings in the contracted
muscle, inducing an arterial pressure reflex, which results in an
important increase in arterial blood pressure and LV afterload
(27,28). Moreover, a twofold increase in plasma norepineph-
rine and a fivefold increase in plasma epinephrine were
demonstrated during handgrip exercise. These changes in
plasma catecholamine levels may represent the basis of chro-
notropic and inotropic response (29). LVEF values for Group
A patients with IDDM were downwardly displaced and fell
below the 95% confidence interval described by the control
group values, indicating an inadequate increase in myocardial
contractility at each comparable level of afterload (Fig. 1).
Nevertheless, these diabetic patients with an abnormal LVEF
response to exercise were able to normalize their response by
PESP inotropic stimulation performed at peak handgrip. Thus,
a defective recruitment of contractility seems to be a major
cause of LV dysfunction during exercise in these patients.
Moreover, the strong relation between the value of LVEF at
peak handgrip and MIBG myocardial uptake (Fig. 4) demon-
strates that the inadequate contractile response during isomet-
ric exercise may be related to impaired function of cardiac
sympathetic nerve fibers. The blunted response to inotropic
dobutamine stimulation in these patients with IDDM offers
additional evidence supporting this hypothesis. PESP can
normalize LVEF at peak handgrip because this inotropic
stimulus is largely independent of the integrity of adrenergic
receptors (19,30). The altered adrenergic innervation is also
suggested by the rapid washout of MIBG from the myocar-
dium in patients with IDDM with an abnormal LV response to
exercise compared with both to normal subjects and patients
with IDDM with a normal LV response to exercise. These data
in humans are in agreement with the defective inotropic
response to catecholamines demonstrated in animal studies
(31–33) and extend the findings of Kreiner et al. (34), who, by
using MIBG scintigraphy, recently showed that sympathetic myo-
cardial dysinnervation is much more common in patients with
IDDM than previously thought and that subclinical LV dysfunc-
tion is related to disturbances in adrenergic cardiac innervation.
As shown in animal models (32,33), the sympathetic ner-
vous system appears to be activated during the early stages of
diabetes on the basis of reports of elevated plasma catechol-
amine levels. Prolonged exposure to catecholamines in humans
induces a downward regulation of adrenergic receptors and
alterations in adrenergic nervous fibers in the myocardium
(35). A decrease in serum T3 levels, hyperglycemia and insulin
deficiency are additional possible factors contributing to the
abnormalities in cardiac innervation in diabetes (36).
As demonstrated by coronary angiography, myocardial isch-
emia was ruled out as a major cause of exercise LV dysfunction
in our study patients. In fact, LV dysfunction induced by exercise
Figure 4. Linear relation between peak hand-
grip LVEF (EF) and myocardial MIBG up-
take normalized for left ventricular mass
(LVM).
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was always of the global, diffuse form, without regional asynergy.
This finding is also strengthened by the lack of angina and ST
segment changes during exercise, in accordance with a previous
study (37) in which thallium imaging revealed no perfusion
defects associated with LV dysfunction in IDDM. Finally, the
normal increase in LV end-diastolic volume index at peak hand-
grip indicates that venous return was not a limiting factor in
abolishing the normal LVEF response during exercise.
Traditionally, detection of autonomic dysfunction has been
based on abnormal responses in heart rate or blood pressure to
various bedside maneuvers. This approach has significant
limitations in that it does not directly assess sympathetic
cardiac innervation, lacks the ability to examine specific ana-
tomic regions and is nonquantitative and thereby subject to
large measurement variability. Our study demonstrates that
there is an important difference in sensitivity between the
traditional approaches, which were unable to demonstrate
cardiac autonomic dysfunction, and the findings obtained both
by myocardial MIBG uptake, which indicated a significant
cardiac autonomic nervous impairment in patients with IDDM
with an abnormal LV response to exercise.
Conclusions. The present study showed that a subset of
uncomplicated young patients with IDDM exhibit an abnormal
LV response to exercise despite normal contractility and that
defective inotropic recruitment plays an important role in
determining exercise LV dysfunction. Results of MIBG scin-
tigraphy and dobutamine infusion revealed functional impair-
ment of cardiac sympathetic nerve fibers as a major cause of
this blunted contractile response during exercise. Finally, these
results suggest that abnormalities in the cardiac beta-
adrenergic system in diabetes may contribute to LV dysfunc-
tion before the appearance of irreversible damage to contrac-
tile machinery and overt heart failure.
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